Health · VanEck · NASDAQ
| Assets under management | $1.02B |
|---|---|
| Expense ratio | 0.36% |
| Category | Health |
| Dividend yield | 1.99% |
| NAV | $119.32 |
| Fund family | VanEck |
| Exchange | NASDAQ |
The largest positions VanEck Pharmaceutical ETF reports, by weight.
| Ticker | Fund | Assets | Expense |
|---|---|---|---|
| XLV | State Street Health Care Select Sector SPDR ETF | $43.39B | 0.08% |
| VHT | Vanguard Health Care Index Fund ETF Shares | $21.81B | 0.09% |
| IBB | iShares Biotechnology ETF | $11.20B | 0.44% |
| XBI | State Street SPDR S&P Biotech ETF | $10.36B | 0.35% |
| IXJ | iShares Global Healthcare ETF | $4.32B | 0.38% |
| IYH | iShares U.S. Healthcare ETF | $3.96B | 0.37% |
| FHLC | Fidelity MSCI Health Care Index ETF | $3.54B | 0.08% |
| IHI | iShares U.S. Medical Devices ETF | $3.45B | 0.37% |